0001437749-23-017046.txt : 20230609
0001437749-23-017046.hdr.sgml : 20230609
20230609152613
ACCESSION NUMBER: 0001437749-23-017046
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230608
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schoenberg Mark
CENTRAL INDEX KEY: 0001763581
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 231004999
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 9 HA TA ASIYA STREET
CITY: RA ANANA
STATE: L3
ZIP: 4365007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-06-08
0001668243
UroGen Pharma Ltd.
URGN
0001763581
Schoenberg Mark
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
Chief Medical Officer
0
Restricted Stock Units
2023-06-08
4
A
0
30000
0
A
Ordinary Shares
30000
30000
D
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2023.
/s/ Jason D. Smith, Attorney-in-Fact
2023-06-09